Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Prasad

Showing results (211-220 of 212) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 212 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2025
A Phase II, Randomized, open-label study to evaluate low-dose Pembrolizumab plus Chemotherapy vs Chemotherapy as Neoadjuvant Therapy for localized Triple Negative Breast Cancer (TNBC). [PLANeT Trial - Pembrolizumab Low Dose in Addition to NACT in TNBC]A Arora, H Bhaskarane, G Tansir, et al.
Applied Optics|May 11, 2010
Research on nonlinear optical materials: an assessmentD H Auston, A A Ballman, P Bhattacharya, et al.
Pageof 22

Showing results (211-220 of 212) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 212 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2025
A Phase II, Randomized, open-label study to evaluate low-dose Pembrolizumab plus Chemotherapy vs Chemotherapy as Neoadjuvant Therapy for localized Triple Negative Breast Cancer (TNBC). [PLANeT Trial - Pembrolizumab Low Dose in Addition to NACT in TNBC]A Arora, H Bhaskarane, G Tansir, et al.
Applied Optics|May 11, 2010
Research on nonlinear optical materials: an assessmentD H Auston, A A Ballman, P Bhattacharya, et al.
Pageof 22